ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

"How do you protect your kids?" Parent issues PSA about dangers of commonly used material in children's playgrounds: 'They've always been toxic' first appeared on The Cool Down.

At just 52 years old, a woman has been diagnosed with Stage 4 lung cancer. A non-smoker who had worked full-time since age 22, she now faces a terminal illness while trying to support her husband and ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's approval noted the patches posed ...

People who have survived cancer as children are at higher risk of developing severe COVID-19, even decades after their ...

BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that ...

Northwestern scientists have developed iSeg, a 3D AI tool that detects and tracks lung tumors on CT scans, even as they move ...